Outcome of Board Meeting for consideration and approval of Audited Financial Results for the quarter and financial year ended March 31, 2026
Awaiting price reaction for this filing.
The company reported Total Income of ₹34,566.01 Lakhs for FY26, up 24% from ₹27,887.52 Lakhs in FY25. Profit before exceptional items was ₹4,721.01 Lakhs, but after accounting for exceptional loss of ₹4,705.30 Lakhs (loss on sale of investment in subsidiary Hindusthan Speciality Chemicals Limited to DCM Shriram Limited), Profit Before Tax stood at just ₹15.70 Lakhs. After tax expenses of ₹803.10 Lakhs, the company recorded a Net Loss of ₹787.40 Lakhs (negative PAT), compared to a loss of ₹179.98 Lakhs in FY25. Basic EPS was ₹(10.91). The Board recommended a final dividend of ₹0.50 per share (25%) and approved a 2:1 bonus issue. Operating cash flow was positive at ₹498.30 Lakhs. The statutory auditor issued an unmodified opinion.
The company turned profitable at operational level but the large exceptional loss from subsidiary sale resulted in a net loss for FY26. The bonus issue will increase share liquidity and retail accessibility, while the dividend provides some return to shareholders despite the loss-making year.